Bristol-Myers Squibb Looks To Feed Oncology Pipeline With New Protein Class
Discovery and development deal could be worth up to $1.3 billion for Waltham, Mass.-based Adnexus.
Discovery and development deal could be worth up to $1.3 billion for Waltham, Mass.-based Adnexus.